Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473693 · ClinicalTrials.gov registry record
Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 1
- Enrollment target
NCT01473693: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01473693 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473693 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the effects of cancer treatment on the brain. Some cancer patients report changes in their memory or thinking after treatment. These changes could be a result of changes in brain structure, such as a change in size or thickness of different parts of the brain. The investigators will look to see if these changes in brain structure happen through the results of magnetic resonance imaging (MRI). The investigators will do this by looking at the brain structure of lung cancer patients who have surgery and chemotherapy versus those who have surgery only.
Interventions
- OTHER MRI Screening Form, MRI, Demographic / Medical Data form
- OTHER MRI Screening Form, MRI. Demographic / Medical Data
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01473693
The ClinicalTrials.gov registry entry for NCT01473693 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI Screening Form, MRI, Demographic / Medical Data form is the first listed.
NCT01473693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01473693 about?
NCT01473693 is a clinical study titled "Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging". The purpose of this study is to learn about the effects of cancer treatment on the brain. Some cancer patients report changes in their memory or thinking after treatment. These changes could be a result of changes in brain structure, such as a change in size or thickness of different parts of the br...
What is the current status of trial NCT01473693?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2011-11. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01473693?
The interventions under investigation include: MRI Screening Form, MRI, Demographic / Medical Data form (OTHER), MRI Screening Form, MRI. Demographic / Medical Data (OTHER).
Who is sponsoring clinical trial NCT01473693?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.